# Therapix Biosciences Ltd. — Form D

Therapix Biosciences Ltd. of GIVATAYIM, L3, a company, filed a Form D exempt-offering notice with the SEC on 2019-04-09. The offering totals $2.2M, of which $2.2M was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2019-04-09
- Form: D
- Accession: 0001213900-19-006016
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $2.2M
- Amount sold: $2.2M
- Minimum investment: $105K
- Investors: 8
- Revenue range: Decline to Disclose
- SEC file number: 021-336762

## Issuer

- Name: Therapix Biosciences Ltd.
- CIK: 0001611746
- Entity type: Other
- Jurisdiction: ISRAEL
- Address: 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR, GIVATAYIM, L3, 5320047
- Phone: 972-3-6167055

## Officers, directors & promoters (28)

_Showing 25 of 28 people._

| Name | Role | Location |
| --- | --- | --- |
| Oz Adler | Related Person | Givatayim, L3 |
| Amit Berger | Related Person | Givatayim, L3 |
| Zohar Heiblum | Related Person | Givatayim, L3 |
| Ascher Shmulewitz | Related Person | Givatayim, L3 |
| Stephen Simes | Related Person | Givatayim, L3 |
| Eric So | Related Person | Givatayim, L3 |
| Yafit Stark | Related Person | Givatayim, L3 |
| Adi Zuloff-Shani | Related Person | Givatayim, L3 |
| Amitay Weiss | Director | Bnei Brak, L3 |
| Amitay Weiss | Executive Officer | Bnei Brak, L3 |
| Eric So | Director | Givatayim, L3 |
| Alon Dayan | Director | Tel Aviv, L3 |
| Dr. Adi Zuloff-Shani | Executive Officer | Tel Aviv, L3 |
| Oz Adler | Executive Officer | Givatayim, L3 |
| Itschak Shrem | Director | Tel Aviv, L3 |
| Itschak Shrem | Executive Officer | Tel Aviv, L3 |
| Moshe Revach | Director | Bnei Brak, L3 |
| Lior Vider | Director | Tel Aviv, L3 |
| Amnon Ben Shay | Director | Tel Aviv, L3 |
| Liat Sidi | Director | Raanana, L3 |
| Adi Zuloff-Shani | Executive Officer | Givatayim, L3 |
| Amnon Ben-Shay | Director | Tel Aviv, L3 |
| Stephen Simes | Director | Givatayim, L3 |
| Ascher Shmulewitz | Director | Givatayim, L3 |
| Ascher Shmulewitz | Executive Officer | Givatayim, L3 |

## Other filings by this issuer (4)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2025-03-03](https://search.stillhousedata.com/formd/0001213900-25-019384) | D | $4.2M | $4.2M |
| [2023-10-19](https://search.stillhousedata.com/formd/0001013762-23-005115) | D | $5.0M | $5.0M |
| [2022-06-08](https://search.stillhousedata.com/formd/0001213900-22-031754) | D | $10.0M | $10.0M |
| [2021-03-09](https://search.stillhousedata.com/formd/0001213900-21-014110) | D | $3.9M | — |

## More

- [CIK 1611746 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1611746&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001213900-19-006016.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.